Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CC
Major Diagnostic Category 16·Grouped by diagnosis·FY 2027
MS-DRG 809 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 16 (MDC 16) with a Complication or Comorbidity (CC). It maps to 63 ICD-10-CM diagnosis codes. For FY 2027 it carries a relative weight of 1.2262 with a geometric mean length of stay of 3.3 days and an arithmetic mean of 4.2 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 1.2262 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 3.3 days (used for transfer payments)
- Average stay:
- 4.2 days (arithmetic mean)
- Post-acute transfer policy:
- No (not subject to it)
Same condition, other severity levels
CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.
| DRG | Title | Relative weight | Mean stay |
|---|---|---|---|
| 808 | Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with MCC | 2.1705 | 5.1 days |
| 809 | Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CC (this page) | 1.2262 | 3.3 days |
| 810 | Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC | 1.0750 | 2.5 days |
Diagnosis codes (63)
As the principal diagnosis, these ICD-10-CM codes can group to DRG 809. 100% of the codes listed are billable.
- D59.0Drug-induced autoimmune hemolytic anemia
- D59.10Autoimmune hemolytic anemia, unspecified
- D59.11Warm autoimmune hemolytic anemia
- D59.12Cold autoimmune hemolytic anemia
- D59.13Mixed type autoimmune hemolytic anemia
- D59.19Other autoimmune hemolytic anemia
- D59.2Drug-induced nonautoimmune hemolytic anemia
- D59.4Other nonautoimmune hemolytic anemias
- D59.5Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
- D59.6Hemoglobinuria due to hemolysis from other external causes
- D59.8Other acquired hemolytic anemias
- D59.9Acquired hemolytic anemia, unspecified
- D60.0Chronic acquired pure red cell aplasia
- D60.1Transient acquired pure red cell aplasia
- D60.8Other acquired pure red cell aplasias
- D60.9Acquired pure red cell aplasia, unspecified
- D61.01Constitutional (pure) red blood cell aplasia
- D61.02Shwachman-Diamond syndrome
- D61.03Fanconi anemia
- D61.09Other constitutional aplastic anemia
- D61.1Drug-induced aplastic anemia
- D61.2Aplastic anemia due to other external agents
- D61.3Idiopathic aplastic anemia
- D61.810Antineoplastic chemotherapy induced pancytopenia
- D61.811Other drug-induced pancytopenia
- D61.818Other pancytopenia
- D61.89Other specified aplastic anemias and other bone marrow failure syndromes
- D61.9Aplastic anemia, unspecified
- D70.0Congenital agranulocytosis
- D70.1Agranulocytosis secondary to cancer chemotherapy
- D70.2Other drug-induced agranulocytosis
- D70.3Neutropenia due to infection
- D70.4Cyclic neutropenia
- D70.8Other neutropenia
- D70.9Neutropenia, unspecified
- D71.1Leukocyte adhesion deficiency
- D71.8Other functional disorders of polymorphonuclear neutrophils
- D71.9Functional disorders of polymorphonuclear neutrophils, unspecified
- D72.0Genetic anomalies of leukocytes
- D80.6Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
- D80.8Other immunodeficiencies with predominantly antibody defects
- D80.9Immunodeficiency with predominantly antibody defects, unspecified
- D81.0Severe combined immunodeficiency [SCID] with reticular dysgenesis
- D81.1Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
- D81.2Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
- D81.4Nezelof's syndrome
- D81.6Major histocompatibility complex class I deficiency
- D81.7Major histocompatibility complex class II deficiency
- D81.82Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
- D81.89Other combined immunodeficiencies
- D81.9Combined immunodeficiency, unspecified
- D82.0Wiskott-Aldrich syndrome
- D82.1Di George's syndrome
- D89.810Acute graft-versus-host disease
- D89.811Chronic graft-versus-host disease
- D89.812Acute on chronic graft-versus-host disease
- D89.813Graft-versus-host disease, unspecified
- I27.841Fontan-associated lymphatic dysfunction
- T86.00Unspecified complication of bone marrow transplant
- T86.01Bone marrow transplant rejection
- T86.02Bone marrow transplant failure
- T86.03Bone marrow transplant infection
- T86.09Other complications of bone marrow transplant
